3 month tirzepatide program TrimRX Semaglutide and Tirzepatide Weight Loss

Although Retatrutide is not yet FDA approved, its generating excitement due to remarkable clinical trial results specifically, the TRIUMPH-1 Phase 3 trial, which showcased an average weight loss of up to 28.3% at 80 weeks

When researching or seeking services, make sure youre referencing the correct company to avoid confusion

Use positive self-talk and realistic self-assessment to support this

In combination with neuropsychiatric drugs, GLP-1RAs did not increase the risk of developing SSIBs

The Department of Health advises you don't take too much as this could be harmful

State Availability: Direct Meds states it currently does not serve Mississippi or Louisiana due to telehealth prescribing restrictions in those states